Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raquel Benítez

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|February 23, 2023
Characterization of the tumor-infiltrating immune repertoire in muscle invasive bladder cancerRaquel Benítez, Katherine Yu, Marina Sirota, et al.
European Journal of Epidemiology|May 31, 2022
Avoiding collider bias in Mendelian randomization when performing stratified analysesClaudia Coscia, Dipender Gill, Raquel Benítez, et al.
Genetic Epidemiology|February 22, 2023
New proposal to address mediation analysis interrogations by using genetic variants as instrumental variablesClaudia Coscia, Esther Molina-Montes, Raquel Benítez, et al.
Frontiers in Oncology|August 17, 2023
Predictive signature of response to neoadjuvant chemotherapy in muscle-invasive bladder cancer integrating mRNA expression, taxonomic subtypes, and clinicopathological featuresAlbert Font, Montserrat Domenech, Jose Luis Ramirez, et al.
Cancers|July 9, 2020
Immunohistochemistry-Based Taxonomical Classification of Bladder Cancer Predicts Response to Neoadjuvant ChemotherapyAlbert Font, Montserrat Domènech, Raquel Benítez, et al.
The New England Journal of Medicine|June 28, 2023
Perioperative Nivolumab and Chemotherapy in Stage III Non-Small-Cell Lung CancerMariano Provencio, Ernest Nadal, José L González-Larriba, et al.
Cell Reports. Medicine|June 23, 2026
Spatial architecture contributes to failure of bulk biomarker-guided neoadjuvant immunotherapy selection in bladder cancer: The DUTRENEO studyEnrique Grande, Mustafa Sibai, Daniela Grases, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|February 23, 2023
Characterization of the tumor-infiltrating immune repertoire in muscle invasive bladder cancerRaquel Benítez, Katherine Yu, Marina Sirota, et al.
European Journal of Epidemiology|May 31, 2022
Avoiding collider bias in Mendelian randomization when performing stratified analysesClaudia Coscia, Dipender Gill, Raquel Benítez, et al.
Genetic Epidemiology|February 22, 2023
New proposal to address mediation analysis interrogations by using genetic variants as instrumental variablesClaudia Coscia, Esther Molina-Montes, Raquel Benítez, et al.
Frontiers in Oncology|August 17, 2023
Predictive signature of response to neoadjuvant chemotherapy in muscle-invasive bladder cancer integrating mRNA expression, taxonomic subtypes, and clinicopathological featuresAlbert Font, Montserrat Domenech, Jose Luis Ramirez, et al.
Cancers|July 9, 2020
Immunohistochemistry-Based Taxonomical Classification of Bladder Cancer Predicts Response to Neoadjuvant ChemotherapyAlbert Font, Montserrat Domènech, Raquel Benítez, et al.
The New England Journal of Medicine|June 28, 2023
Perioperative Nivolumab and Chemotherapy in Stage III Non-Small-Cell Lung CancerMariano Provencio, Ernest Nadal, José L González-Larriba, et al.
Cell Reports. Medicine|June 23, 2026
Spatial architecture contributes to failure of bulk biomarker-guided neoadjuvant immunotherapy selection in bladder cancer: The DUTRENEO studyEnrique Grande, Mustafa Sibai, Daniela Grases, et al.
Pageof 1